rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Gabriele M. Cerrone

Director and 10% owner

Company insider

Files Form 4 as: Director and 10% owner, Tiziana Life Sciences; Executive Chairman, OKYO Pharma; Director and 10% owner, Accustem Sciences.

Every Form 4 they filed

In numbers

Trades disclosed
41
Buys
23
Sells
0
Bought
$1.3M
Sold
$0
Companies
3
Companies where not an officer
2
First trade
25 Apr 2022
Last trade
21 Jul 2026
Last filed
7 Aug 2026

Companies traded

Where they are an officer
OKYO OKYO PharmaDirector, Officer, 10% owner · Biotechnology · last 21 Jul 20266 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
TLSA Tiziana Life SciencesDirector, 10% owner · Biotechnology · last 21 Jul 20262 buys · 0 sells
Accustem SciencesDirector, 10% owner · last 13 Jun 202515 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
03Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
21 Jul 2026filed 7 Aug 2026TLSA Tiziana Life SciencesBiotechnologySEC FORM 4 Bought$42K42,357 at $0.99filing
21 Jul 2026filed 7 Aug 2026TLSA Tiziana Life SciencesBiotechnologySEC FORM 4 Bought$42K42,357 at $0.99filing
21 Jul 2026filed 7 Aug 2026OKYO OKYO PharmaBiotechnologySEC FORM 4 Bought$33K22,500 at $1.45filing
21 Jul 2026filed 7 Aug 2026OKYO OKYO PharmaBiotechnologySEC FORM 4 Bought$33K22,500 at $1.45filing
21 Jul 2026filed 23 Jul 2026TLSA Tiziana Life SciencesBiotechnologySEC FORM 4 Code A$42K42,357 at $0.99filing
21 Jul 2026filed 23 Jul 2026TLSA Tiziana Life SciencesBiotechnologySEC FORM 4 Code A$42K42,357 at $0.99filing
21 Jul 2026filed 23 Jul 2026OKYO OKYO PharmaBiotechnologySEC FORM 4 Code A$33K22,500 at $1.45filing
21 Jul 2026filed 23 Jul 2026OKYO OKYO PharmaBiotechnologySEC FORM 4 Code A$33K22,500 at $1.45filing
20 Jul 2026filed 7 Aug 2026OKYO OKYO PharmaBiotechnologySEC FORM 4 Bought$35K25,000 at $1.40filing
20 Jul 2026filed 7 Aug 2026OKYO OKYO PharmaBiotechnologySEC FORM 4 Bought$35K25,000 at $1.40filing
20 Jul 2026filed 21 Jul 2026OKYO OKYO PharmaBiotechnologySEC FORM 4 Code A$35K25,000 at $1.40filing
20 Jul 2026filed 21 Jul 2026OKYO OKYO PharmaBiotechnologySEC FORM 4 Code A$35K25,000 at $1.40filing
12 Jun 2026filed 7 Aug 2026TLSA Tiziana Life SciencesBiotechnologySEC FORM 4 Bought$17K15,000 at $1.11filing
12 Jun 2026filed 7 Aug 2026TLSA Tiziana Life SciencesBiotechnologySEC FORM 4 Bought$17K15,000 at $1.11filing
12 Jun 2026filed 17 Jun 2026TLSA Tiziana Life SciencesBiotechnologySEC FORM 4 Code A$17K15,000 at $1.11filing
12 Jun 2026filed 17 Jun 2026TLSA Tiziana Life SciencesBiotechnologySEC FORM 4 Code A$17K15,000 at $1.11filing
8 Jun 2026filed 10 Jun 2026OKYO OKYO PharmaBiotechnologySEC FORM 4 Code A$516K300,000 at $1.72filing
8 Jun 2026filed 10 Jun 2026OKYO OKYO PharmaBiotechnologySEC FORM 4 Code A$516K300,000 at $1.72filing
13 Jun 2025filed 16 Jun 2025Accustem SciencesSEC FORM 4 Bought$2,0002,000 at $1.00filing
13 Jun 2025filed 16 Jun 2025Accustem SciencesSEC FORM 4 Bought$440400 at $1.10filing

Sectors

Health Care8
Not placed15

Buys in green, sells in red, by the company’s sector.

Related people

Flavio MantelliChief Medical Officer · Chief Medical Officer at OKYO Pharma, filing Form 4 there in the last year
John P. BrancaccioDirector · Director at OKYO Pharma, filing Form 4 there in the last year
Rajkumar Patil VChief Scientific Officer · Chief Scientific Officer at OKYO Pharma, filing Form 4 there in the last year
Robert John DempseyChief Executive Officer · Chief Executive Officer at OKYO Pharma, filing Form 4 there in the last year
Gary S. JacobChief Development Officer · Chief Development Officer at OKYO Pharma, filing Form 4 there in the last year
Ivor ElrifiChief Executive Officer · Also traded TLSA in the last 90 days